{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:28:38Z","timestamp":1787671718415,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Dual-antiplatelet therapy (DAPT), the combined administration of aspirin and clopidogrel, is commonly used to prevent thrombus formation in patients at an increased risk of thromboembolic complications. However, current guidelines regarding DAPT safety following primary elective total hip arthroplasty (THA) and total knee arthroplasty (TKA) are unclear. We sought to compare the odds of 90-day bleeding and thromboembolic complications among patients receiving DAPT relative to clopidogrel alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      All patients who underwent primary TKA or THA between 2016 and 2021 were identified using the Premier Healthcare Database. Patients who received DAPT for postoperative thromboprophylaxis were compared with those receiving only clopidogrel for demographic and comorbidity differences. Chi-square analysis was employed to evaluate differences between categorical variables, whereas independent\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -tests were used for continuous variables. Univariate and multivariable regression analyses were used to assess differences in 90-day outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In total, 18,117 primary THA and TKA patients (DAPT: 83.0%; clopidogrel: 17.0%) were identified. After adjusting for confounders, DAPT patients did not demonstrate increased rates of bleeding complications, transfusion, acute anemia, hematoma, or hemorrhage compared with those receiving clopidogrel alone. In addition, no significant differences were found in rates of deep vein thrombosis, pulmonary embolism, myocardial infarction, or mortality between the cohorts. However, compared with patients receiving clopidogrel, those receiving DAPT were more likely to suffer stroke (adjusted odds ratio 2.34, 95% confidence interval: 1.16 to 4.69,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.017).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Despite the notable efficacy of DAPT in reducing thromboembolic risk, patients on DAPT did not have higher rates of postoperative bleeding complications within the early postoperative period following elective THA or TKA. These findings suggest that patients on long-term DAPT may safely resume these medications after THA or TKA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-00693","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:00:10Z","timestamp":1765836010000},"page":"e1480-e1487","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dual-Antiplatelet Therapy Is Not Associated With Greater Odds of Postoperative Bleeding Following Elective Total Joint Arthroplasty"],"prefix":"10.5435","volume":"34","author":[{"given":"Sagar","family":"Telang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Aron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Stronach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Stambough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay R.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-1702","authenticated-orcid":false,"given":"Nathanael D.","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"R1-20260501","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Clopidogrel in unstable angina to prevent recurrent events trial investigators: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-20260501","first-page":"57","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"2011","author":"Werns","year":"2011","journal-title":"Yearb Crit Care Med"},{"key":"R3-20260501","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/eurheartj\/ehi074","article-title":"Clopidogrel administration prior to coronary artery bypass grafting surgery: The cardiologist's panacea or the surgeon's headache?","volume":"26","author":"Eimedlam Daboyce","year":"2005","journal-title":"Eur Heart J"},{"key":"R4-20260501","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archsurg.144.1.69","article-title":"Antiplatelet agents in the perioperative period","volume":"144","author":"O'Riordan","year":"2009","journal-title":"Arch Surg"},{"key":"R5-20260501","doi-asserted-by":"crossref","first-page":"768","DOI":"10.5435\/00124635-201112000-00007","article-title":"Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty","volume":"19","author":"Mont","year":"2011","journal-title":"J Am Acad Orthop Surg"},{"key":"R6-20260501","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ejcts.2009.05.032","article-title":"Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study","volume":"36","author":"Firanescu","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"R7-20260501","first-page":"453","article-title":"The effect of preoperative aspirin use on postoperative bleeding and perioperative myocardial infarction in patients undergoing coronary artery bypass surgery","volume":"14","author":"Ghaffarinejad","year":"2007","journal-title":"Cardiol J"},{"key":"R9-20260501","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"R10-20260501","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1378\/chest.06-2088","article-title":"Documenting research in scientific articles: Guidelines for authors: 3. Reporting multivariate analyses","volume":"131","author":"Lang","year":"2007","journal-title":"Chest"},{"key":"R11-20260501","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.arth.2024.06.025","article-title":"Super-obesity is associated with an increased risk of complications following primary total knee arthroplasty","volume":"39","author":"Palmer","year":"2024","journal-title":"J Arthroplasty"},{"key":"R12-20260501","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: A report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"R13-20260501","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: A report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"R14-20260501","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jcin.2020.12.005","article-title":"Stent thrombosis risk over time on the basis of clinical presentation and platelet reactivity: Analysis from ADAPT-DES","volume":"14","author":"Chau","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"R15-20260501","doi-asserted-by":"crossref","first-page":"e1371","DOI":"10.4244\/EIJ-D-21-00904","article-title":"Antiplatelet therapy after percutaneous coronary intervention","volume":"17","author":"Angiolillo","year":"2022","journal-title":"EuroIntervention"},{"key":"R16-20260501","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.arth.2022.04.005","article-title":"Is it safe to continue clopidogrel in elective hip and knee arthroplasty?","volume":"37","author":"Maxfield","year":"2022","journal-title":"J Arthroplasty"},{"key":"R17-20260501","first-page":"CD012584","article-title":"Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery","volume":"7","author":"Lewis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-20260501","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/1076029612470489","article-title":"Prethrombotic state and cardiac events in patients with coronary heart disease during noncardiac surgery","volume":"20","author":"Zheng","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"R19-20260501","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/CIRCULATIONAHA.115.017787","article-title":"Perioperative management to reduce cardiovascular events","volume":"133","author":"Smilowitz","year":"2016","journal-title":"Circulation"},{"key":"R20-20260501","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.arth.2024.11.020","article-title":"Alarmingly high rates of deep vein thrombosis and pulmonary embolism following closed reduction for dislocated total hip arthroplasty","volume":"40","author":"Telang","year":"2025","journal-title":"J Arthroplasty"},{"key":"R21-20260501","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3390\/jcm11071754","article-title":"The risk of bleeding and adverse events with clopidogrel in elective hip and knee arthroplasty patients","volume":"11","author":"Wu","year":"2022","journal-title":"J Clin Med"},{"key":"R22-20260501","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1445-2197.2010.05631.x","article-title":"Clopidogrel dilemma for orthopaedic surgeons","volume":"81","author":"Steele","year":"2011","journal-title":"ANZ J Surg"},{"key":"R23-20260501","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11420-010-9171-2","article-title":"The management of patients on dual antiplatelet therapy undergoing orthopedic surgery","volume":"6","author":"Kim","year":"2010","journal-title":"HSS J"},{"key":"R24-20260501","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2147\/CIA.S174896","article-title":"Antithrombotic therapies for elderly patients: Handling problems originating from their comorbidities","volume":"13","author":"Arahata","year":"2018","journal-title":"Clin Interv Aging"},{"key":"R25-20260501","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.arth.2013.06.008","article-title":"Continuing clopidogrel during elective total hip and knee arthroplasty: Assessment of bleeding risk and adverse outcomes","volume":"29","author":"Jacob","year":"2014","journal-title":"J Arthroplasty"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-00693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:51:22Z","timestamp":1787669482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-00693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-00693","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-05-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}